NYSE:JNJ - Johnson & Johnson News Headlines Sign in or create an account to add this stock to your watchlist. Get Started $135.05 -1.30 (-0.95 %) (As of 02/21/2019 12:32 PM ET)Previous Close$136.35Today's Range$134.28 - $135.6852-Week Range$118.62 - $148.99Volume202,732 shsAverage Volume7.00 million shsMarket Capitalization$362.33 billionP/E Ratio16.51Dividend Yield2.65%Beta0.68 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Headlines Johnson & Johnson (NYSE JNJ) News Headlines Source: All Sources Trusted Sources MarketBeat.com Bloomberg MarketWatch Motley Fool NASDAQ Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance DateHeadlineMarkets Right Now: Stocks move lower on Wall Streetmarketbeat.com - February 21 at 12:29 PMThe Latest From Johnson & Johnson's Asbestos Scandalfeeds.benzinga.com - February 21 at 10:55 AMMarkets Right Now: Stocks open lower on Wall Streetmarketbeat.com - February 21 at 9:48 AMJohnson & Johnson says it’s been subpoenaed by SEC, Justice Departmentwww.marketwatch.com - February 21 at 8:13 AMJohnson & Johnson receives federal subpoenasseekingalpha.com - February 21 at 8:13 AMJohnson & Johnson Subpoenaed for Talc Safety Informationwww.thestreet.com - February 21 at 8:13 AMJohnson & Johnson Faces More Overhang From Talc and Asbestos Woes247wallst.com - February 21 at 8:13 AMNike, Lyft, J&J, Kraft Heinz and Trade Deal Progress - 5 Things You Must Knowfinance.yahoo.com - February 21 at 8:13 AMUS STOCKS-Futures flat as U.S.-China talks progressfinance.yahoo.com - February 21 at 8:13 AMJohnson & Johnson receives federal subpoenas related to baby powder litigation - Reuterswww.reuters.com - February 21 at 5:16 AMCNBC Exclusive: CNBC Transcript: Johnson & Johnson Chairman and CEO Alex Gorsky Speaks to CNBC's Jim Cramer Todaywww.msn.com - February 20 at 6:59 PMJohnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Knowfinance.yahoo.com - February 20 at 6:59 PMJohnson & Johnson Looks Undervalued: Time To Buy? - Seeking Alphaseekingalpha.com - February 20 at 8:09 AMNasal spray developed by Johnson & Johnson may be the key to fighting treatment resistant depressionfinance.yahoo.com - February 20 at 8:09 AMCNBC Exclusive: CNBC Transcript: Johnson & Johnson Chairman and CEO Alex Gorsky Speaks to CNBC's Jim Cramer Today - CNBCwww.cnbc.com - February 19 at 7:11 PMJohnson & Johnson (JNJ) Management presents at CAGNY Conference (Transcript) - Seeking Alphaseekingalpha.com - February 19 at 7:11 PMGM, Bank of America and Johnson & Johnson earn top scores in new study of corporate gender equality - CNBCwww.cnbc.com - February 19 at 7:11 PMGM, Bank of America and Johnson & Johnson earn top scores in new study of corporate gender equalityfinance.yahoo.com - February 19 at 7:10 PMThe Charts of Johnson & Johnson Do Not Yet Convince Me of the Bull Casefinance.yahoo.com - February 19 at 7:10 PMNew Road Rules for This Market: Cramer's 'Mad Money' Recap (Tues. 2/19/19)finance.yahoo.com - February 19 at 7:10 PMNovartis Positioned to Be World's Top Drug Seller in 2024finance.yahoo.com - February 18 at 6:19 PMReviewing Cambrex (CBM) & Johnson & Johnson (JNJ)www.americanbankingnews.com - February 17 at 3:12 PMCramer Remix: This single statement by Nvidia speaks volumesfinance.yahoo.com - February 16 at 8:08 AMJohnson & Johnson International Fin Svc Co -- Moody's announces completion of a periodic review of ratings of Johnson & Johnsonfinance.yahoo.com - February 16 at 8:08 AMJohnson & Johnson CEO on Apple Watch collaboration: 'Ultimately, we're going to save lives'finance.yahoo.com - February 16 at 8:08 AMJohnson & Johnson Depression Drug Nears FDA Approval - Bloombergwww.bloomberg.com - February 15 at 6:44 PMIs Johnson & Johnson CEO Alex Gorsky Earning His Pay? - Investorplace.cominvestorplace.com - February 15 at 6:44 PMJohnson & Johnson supplier seeks bankruptcy over talc lawsuits - Reuterswww.reuters.com - February 15 at 6:44 PMJohnson & Johnson (JNJ) to Acquire Auris Health for $3.4B - Nasdaqwww.nasdaq.com - February 15 at 6:44 PMDid Johnson & Johnson Just Spit in Alphabet's Face? - The Motley Foolwww.fool.com - February 15 at 6:44 PMJohnson & Johnson CEO on Apple Watch collaboration: 'Ultimately, we're going to save lives'www.cnbc.com - February 15 at 6:40 PMJohnson & Johnson will acquire surgical robotics company Auris Healthwww.marketwatch.com - February 15 at 8:08 AM Analysts Anticipate Johnson & Johnson (JNJ) Will Announce Quarterly Sales of $19.67 Billionwww.americanbankingnews.com - February 15 at 4:18 AMJohnson & Johnson: Regulatory Headwinds Compromise Half Of Future Revenue Streamsseekingalpha.com - February 14 at 6:34 PMJohnson & Johnson to Participate in the 8th Annual SVB Leerink Global Healthcare Conferencewww.marketwatch.com - February 14 at 6:34 PMJohnson & Johnson (JNJ) to Acquire Auris Health for $3.4Bfinance.yahoo.com - February 14 at 6:34 PMIs Johnson & Johnson CEO Alex Gorsky Earning His Pay?investorplace.com - February 14 at 1:46 PM[$$] Johnson & Johnson to Buy Surgical Robotics Makerfinance.yahoo.com - February 14 at 8:06 AMNeutral Media Coverage Likely to Impact Johnson & Johnson (JNJ) Share Pricewww.americanbankingnews.com - February 14 at 5:53 AMJohnson & Johnson to Buy Surgical Robotics Maker Auriswww.wsj.com - February 14 at 4:37 AMJohnson & Johnson to Buy Robotic Surgery Company Auris Health for $3.4 Billionwww.thestreet.com - February 13 at 6:46 PMJohnson & Johnson Wins FDA Panel Backing For Nasal Spray Depression Drug; PDUFA Date Awaitswww.benzinga.com - February 13 at 6:46 PMJohnson & Johnson to acquire Auris Health for $3.4Bseekingalpha.com - February 13 at 6:46 PMJ&J's (JNJ) Depression Treatment Gets FDA Committee's Nodfinance.yahoo.com - February 13 at 6:46 PMTraders boost the wrong stock for a second time after J&J takeoverwww.cnbc.com - February 13 at 3:20 PMZacks: Brokerages Expect Johnson & Johnson (JNJ) to Post $2.09 Earnings Per Sharewww.americanbankingnews.com - February 13 at 11:01 AMJohnson & Johnson will pay $3.4 billion for robotic surgery firm Auriswww.latimes.com - February 13 at 10:55 AMJohnson & Johnson to buy Auris Health for $3.4 billionwww.cnbc.com - February 13 at 9:52 AMPRESS DIGEST-New York Times business news - Feb 13finance.yahoo.com - February 13 at 8:05 AMU.S. FDA panel recommends approval of Johnson & Johnson's depression drugwww.nasdaq.com - February 12 at 7:30 PM This page was last updated on 2/21/2019 by MarketBeat.com StaffFeatured Article: How Do You Calculate Return on Equity (ROE)?